News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
754,074 Results
Type
Article (73497)
Company Profile (708)
Press Release (679869)
Section
Business (207689)
Career Advice (3283)
Deals (37297)
Drug Delivery (105)
Drug Development (85329)
Employer Resources (172)
FDA (16980)
Job Trends (16496)
News (358450)
Policy (35321)
Tag
Academia (2966)
Alliances (50811)
Alzheimer's disease (1303)
Approvals (16885)
Artificial intelligence (140)
Bankruptcy (337)
Best Places to Work (12395)
Biotechnology (486)
Breast cancer (117)
Cancer (1020)
Career advice (2772)
Cell therapy (239)
Clinical research (67144)
Collaboration (361)
Compensation (178)
COVID-19 (2729)
C-suite (95)
Data (969)
Diabetes (141)
Diagnostics (6589)
Drug pricing (92)
Earnings (78599)
Employer resources (150)
Events (118193)
Executive appointments (271)
FDA (17465)
Funding (320)
Gene therapy (173)
GLP-1 (632)
Government (4829)
Healthcare (20580)
Infectious disease (2812)
Inflammatory bowel disease (113)
Interviews (616)
IPO (17395)
Job creations (4488)
Job search strategy (2329)
Layoffs (475)
Legal (8352)
Lung cancer (166)
Manufacturing (174)
Medical device (14261)
Medtech (14266)
Mergers & acquisitions (19965)
Metabolic disorders (399)
Neuroscience (1564)
NextGen Class of 2024 (7517)
Non-profit (5031)
Northern California (1336)
Obesity (229)
Opinion (234)
Patents (102)
People (61971)
Pharmaceutical (139)
Phase I (20785)
Phase II (29264)
Phase III (22030)
Pipeline (320)
Postmarket research (3065)
Preclinical (9250)
Radiopharmaceuticals (254)
Rare diseases (209)
Real estate (6906)
Regulatory (23467)
Research institute (2621)
Resumes & cover letters (512)
Southern California (1202)
Startups (3861)
United States (13250)
Vaccines (595)
Weight loss (179)
Date
Today (252)
Last 7 days (1082)
Last 30 days (3479)
Last 365 days (37931)
2024 (33259)
2023 (42217)
2022 (53486)
2021 (58389)
2020 (57424)
2019 (51042)
2018 (38750)
2017 (35182)
2016 (35068)
2015 (41058)
2014 (34932)
2013 (32953)
2012 (32765)
2011 (32920)
2010 (31949)
Location
Africa (1096)
Arizona (181)
Asia (44393)
Australia (7979)
California (3112)
Canada (1216)
China (234)
Colorado (138)
Connecticut (149)
Europe (102318)
Florida (428)
Georgia (115)
Illinois (374)
Indiana (203)
Kansas (102)
Maryland (590)
Massachusetts (2599)
Michigan (164)
Minnesota (281)
New Jersey (916)
New York (911)
North Carolina (806)
Northern California (1336)
Ohio (139)
Pennsylvania (803)
South America (1417)
Southern California (1202)
Texas (440)
Washington State (376)
754,074 Results for "university of new south wales".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor
Astellas Pharma Inc. announced the opening of a new $90 million, state-of-the-art center at 480 Forbes Boulevard in South San Francisco, CA.
May 8, 2024
·
3 min read
Business
Myeloid Therapeutics and New South Wales (NSW) Government in Australia Announce Collaboration to Design, Build, and Launch State-of-the-Art GMP Manufacturing Facility Dedicated to RNA Immunotherapies
Myeloid Therapeutics, Inc., a clinical-stage mRNA-immunotherapy company, announced that it will collaborate with the New South Wales Government in Australia to create a world-class RNA manufacturing and research facility.
February 21, 2023
·
3 min read
Press Releases
Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings
October 8, 2024
·
6 min read
Press Releases
The Medical University of South Carolina Becomes First in South Carolina to Adopt MOLLI Surgical’s Advanced Breast Cancer Technology
July 25, 2024
·
4 min read
Business
Parse Biosciences Announces Partnership with Gencell Pharma to Extend its Reach in South America
Parse Biosciences today announced an agreement with Bogotá, Colombia-based Gencell Pharma to extend Parse’s reach in Colombia specifically and also across South America.
June 25, 2024
·
2 min read
Antengene Announces XPOVIO® (selinexor) National Health Insurance Service Approval for Reimbursement in South Korea
Antengene Corporation Limited announced that South Korea’s National Health Insurance Service has approved the reimbursement of XPOVIO® for the treatment of adult patients with relapsed or refractory multiple myeloma.
June 26, 2024
·
5 min read
Lone Star Bio
Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner
Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care, announced that its founder, president and chief executive officer, Derek Maetzold, has been named by Ernst & Young LLP as an Entrepreneur Of The Year® 2024 Gulf South Award winner.
June 14, 2024
·
5 min read
Press Releases
BioIVT LLC and KRISHGEN BioSystems Announce Exclusive Commercial Agreement to Enhance Clinical Research in South Asia
November 7, 2024
·
3 min read
Press Releases
Solis Mammography Announces Acquisition of Breast Center of Acadiana in South Louisiana
October 10, 2024
·
2 min read
Business
Tiba Biotech and the Australian State of New South Wales Enter Partnership to Address Emergency Animal Disease Threats
Tiba Biotech , a preclinical biopharmaceutical company, today announced it has entered into a five-year, multi-million US dollar agreement with the Australian state government of New South Wales (NSW) to develop next-generation mRNA vaccines against emergency animal diseases that threaten Australia’s livestock industry and domestic food security.
September 27, 2022
·
4 min read
1 of 75,408
Next